HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pathogenesis of bullous pemphigoid.

Abstract
Bullous pemphigoid, the most common autoimmune blistering disease, is induced by autoantibodies against type XVII collagen. Passive transfer of IgG or IgE antibodies against type XVII collagen into animals has revealed not only the pathogenicity of these antibodies but also the subsequent immune responses, including complement activation, mast cell degranulation, and infiltration of neutrophils and/or eosinophils. In vitro studies on ectodomain shedding of type XVII collagen have also provided basic knowledge on the development of bullous pemphigoid. The pathogenic role of autoreactive CD4+ T lymphocytes in the development of the pathogenic autoantibodies to type XVII collagen should also be noted.
AuthorsHideyuki Ujiie, Wataru Nishie, Hiroshi Shimizu
JournalImmunology and allergy clinics of North America (Immunol Allergy Clin North Am) Vol. 32 Issue 2 Pg. 207-15, v (May 2012) ISSN: 1557-8607 [Electronic] United States
PMID22560134 (Publication Type: Journal Article)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Chemical References
  • Autoantibodies
  • Autoantigens
  • Immunoglobulin G
  • Non-Fibrillar Collagens
  • collagen type XVII
  • Immunoglobulin E
Topics
  • Adoptive Transfer
  • Animals
  • Autoantibodies (immunology)
  • Autoantigens (genetics, immunology)
  • Blister (immunology)
  • CD4-Positive T-Lymphocytes (immunology)
  • Complement Activation
  • Disease Models, Animal
  • Humans
  • Immunoglobulin E (immunology)
  • Immunoglobulin G (immunology)
  • Mice
  • Mice, Knockout
  • Non-Fibrillar Collagens (genetics, immunology)
  • Pemphigoid, Bullous (genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: